@article{1d57c74f9fb64393bc7e74a10f096e32,
title = "Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance",
author = "Patnaik, {M. M.} and Zahid, {M. F.} and Lasho, {T. L.} and C. Finke and Ketterling, {R. L.} and N. Gangat and Robertson, {K. D.} and Hanson, {C. A.} and A. Tefferi",
note = "Funding Information: The current article is supported in part by grants from the {\textquoteleft}The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA.{\textquoteright} This publication was supported by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We would like to acknowledge Ryan Hlady, Ph.D for his help with Figure 1.",
year = "2016",
doi = "10.1038/BCJ.2016.82",
language = "English (US)",
volume = "6",
journal = "Blood cancer journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "9",
}